The physiology of endocrine systems with ageing
AW van den Beld, JM Kaufman, MC Zillikens… - The Lancet Diabetes & …, 2018 - thelancet.com
During ageing, the secretory patterns of the hormones produced by the hypothalamic–
pituitary axis change, as does the sensitivity of the axis to negative feedback by end …
pituitary axis change, as does the sensitivity of the axis to negative feedback by end …
International Society for the Study of Women's Sexual Health clinical practice guideline for the use of systemic testosterone for hypoactive sexual desire disorder in …
ABSTRACT Background The Global Consensus Position Statement on the Use of
Testosterone Therapy for Women (Global Position Statement) recommended testosterone …
Testosterone Therapy for Women (Global Position Statement) recommended testosterone …
2016 IMS Recommendations on women's midlife health and menopause hormone therapy
RJ Baber, N Panay, A Fenton - Climacteric, 2016 - Taylor & Francis
Abstract The International Menopause Society (IMS) has produced these new 2016
recommendations on women's midlife health and menopause hormone therapy (MHT) to …
recommendations on women's midlife health and menopause hormone therapy (MHT) to …
Global consensus position statement on the use of testosterone therapy for women
SR Davis, R Baber, N Panay, J Bitzer… - The journal of sexual …, 2019 - academic.oup.com
This Statement is being simultaneously published in the journals Climacteric, Maturitas,
Journal of Sexual Medicine, and Journal of Clinical Endocrinology and Metabolism on …
Journal of Sexual Medicine, and Journal of Clinical Endocrinology and Metabolism on …
Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data
Background The benefits and risks of testosterone treatment for women with diminished
sexual wellbeing remain controversial. We did a systematic review and meta-analysis to …
sexual wellbeing remain controversial. We did a systematic review and meta-analysis to …
Sexual health in menopause
I Scavello, E Maseroli, V Di Stasi, L Vignozzi - Medicina, 2019 - mdpi.com
Sexual function worsens with advancing menopause status. The most frequently reported
symptoms include low sexual desire (40–55%), poor lubrication (25–30%) and dyspareunia …
symptoms include low sexual desire (40–55%), poor lubrication (25–30%) and dyspareunia …
Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline
Objective: To update practice guidelines for the therapeutic use of androgens in women.
Participants: A Task Force appointed by the Endocrine Society, American Congress of …
Participants: A Task Force appointed by the Endocrine Society, American Congress of …
[HTML][HTML] The International Society for the Study of Women's Sexual Health process of care for management of hypoactive sexual desire disorder in women
AH Clayton, I Goldstein, NN Kim, SE Althof… - Mayo Clinic …, 2018 - Elsevier
Abstract The International Society for the Study of Women's Sexual Health process of care
(POC) for management of hypoactive sexual desire disorder (HSDD) algorithm was …
(POC) for management of hypoactive sexual desire disorder (HSDD) algorithm was …
Menopause—Biology, consequences, supportive care, and therapeutic options
SR Davis, JA Pinkerton, N Santoro, T Simoncini - Cell, 2023 - cell.com
Menopause is the cessation of ovarian function, with loss of reproductive hormone
production and irreversible loss of fertility. It is a natural part of reproductive aging. The …
production and irreversible loss of fertility. It is a natural part of reproductive aging. The …
Sexual well-being after menopause: an international menopause society white paper
JA Simon, SR Davis, SE Althof, P Chedraui… - …, 2018 - Taylor & Francis
Sexual well-being frequently declines following the menopause transition and can be
associated with significant personal and relationship distress. This distress is the hallmark of …
associated with significant personal and relationship distress. This distress is the hallmark of …